SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Analysts/Institutional Investor Meet/Con. Call09-06-2022
09-06-2022
SMS PHARMACEUTICALS LTD. - 532815 - Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2022
Disclosure of Related Party Transactions for the half year ended 31st March, 202207-06-2022
Earnings Call for Q4FY22 of SMS Pharmaceuticals
Conference Call with SMS Pharmaceuticals Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.06-06-2022
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Recording of Analysts/Institutional Investor Meet/Con. Call06-06-2022
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investors Conference Call02-06-2022
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Q4 & FY 2022 Financial Results02-06-2022
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Q4 & FY 2022 Financial Results02-06-2022
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cuttings01-06-2022
SMS PHARMACEUTICALS LTD. - 532815 - Correction In The Notes To Financial Results Submitted For The Quarter And Year Ended 31St March, 2022
Correction in the Notes to Financial Results submitted for the Quarter and Year ended 31st March, 202230-05-2022
SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the period ended 31st March, 202230-05-2022